Hikma launches Alvimopan
Alvimopan Capsules are indicated to accelerate the time to upper and lower gastrointestinal recovery following surgeries that include partial bowel resection with primary anastomosis.
Hikma is offering Alvimopan Capsules in 12 mg doses.
Alvimopan Capsules are indicated to accelerate the time to upper and lower gastrointestinal recovery following surgeries that include partial bowel resection with primary anastomosis.
[Read more: Hikma intros Kloxxado]
Alvimopan Capsules had a market value of approximately $43 million in the 12 months ending November 2023, per IQVIA.